CT70

Across TCGA pan-cancer cohorts, CT70 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated CT70 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher CT70 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CT70 expression acts as an unfavorable survival marker, although some lineages such as PAAD and STAD show a favorable association.

LIHC, READ, and UVM are the cancer types where CT70 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.344	0.668	<.001	57	view →
READ	OS	Quartile	II,III,IV	0.239	0.753	<.001	34	view →
UVM	DFS	Quartile	All	0.572	0.819	.009	28	view →
DLBC	OS	Tertile	III,IV	0.172	1.000	.014	27	view →
PAAD	OS	Quartile	All	0.587	0.241	.003	23	view →
KIRP	DFS	Median	IV	0.039	0.594	.006	20	view →
STAD	OS	Median	IV	0.564	0.192	.004	18	view →
SKCM	DFS	Median	IV	0.763	0.187	.006	10	view →
ACC	OS	Median	IV	0.915	0.295	.003	9	view →
THCA	OS	Tertile	III,IV	1.000	0.749	.014	7	view →
LAML	DFS	Quartile	All	0.781	0.500	.027	6	view →
BLCA	OS	Median	II,III,IV	0.741	0.674	.027	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

CT70–LIHC (OS)

Open the LIHC breakdown →